MASK
3 E Network Technology Group Ltd Class A Ordinary Shares
There isn't enough reported data to score MASK yet.
SNDK
Sandisk Corporation
SNDK's fundamentals are strong: revenue more than tripled and its operating margin went from −19% to 72%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
MASK Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| Unavailable | |
| Strong |
MASK's profitability and balance sheet are currently healthy. There isn't enough data to rate its revenue and cash flow.
SNDK Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
SNDK's revenue, profitability, cash flow and balance sheet are all currently strong.
MASK PE Valuation
MASK has no meaningful PE right now: it lost money over the past year.
SNDK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 3.8x | $937 | — |
| Current | 7.5x | $937 | — |
| Cheap | 17x | $2,173 | +132% |
| Fair | 24x | $3,048 | +225% |
| Expensive | 59x | $7,452 | +695% |
Historical ranges are pointers, not guarantees.
SNDK's PE is 7.5x, but its earnings don't support one, so it isn't a reliable read right now.
MASK Forward outlook
There aren't enough analyst estimates for MASK to show an outlook.
SNDK Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| High |
Analysts expect strong earnings and revenue growth for SNDK, with profitability improving.
MASK Earnings Per Share
MASK and SNDK do not have enough comparable growth data to identify a winner.
SNDK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $247.30 | +97% |
| Q3 2026 | $125.61 | +$137.63 |
| Q2 2026 | $73.76 | +$85.07 |
| Q2 2025 | -$11.31 | -$6.65 |
SNDK has returned to profit: it earned $125.61 per share over the past year, after losing money the year before.
MASK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $7.2M | +321% |
| Q2 2025 | $1.7M | +7.4% |
| Q4 2024 | $3.1M | +5.3% |
| Q2 2024 | $1.6M | +13% |
| Q4 2023 | $3M | +999% |
MASK's revenue has grown year over year every quarter since mid-2024: $7M last quarter, up 352% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 3.6% | -59 points |
| Q2 2025 | 39% | -26 points |
| Q4 2024 | 40% | +12 points |
| Q3 2024 | 40% | -36 points |
| Q2 2024 | 63% | +82 points |
| Q1 2024 | 65% | N/A |
| Q4 2023 | 27% | N/A |
| Q2 2023 | 76% | N/A |
MASK's operating margin was 3.6% last quarter, down 59 points from the same quarter a year ago.
SNDK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11B | +378% |
| Q2 2026 | $9B | +372% |
| Q1 2026 | $6B | +251% |
| Q4 2025 | $3B | +61% |
| Q3 2025 | $2.3B | +23% |
| Q2 2025 | $1.9B | +8% |
| Q1 2025 | $1.7B | -0.6% |
| Q4 2024 | $1.9B | +13% |
SNDK has the edge over MASK in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 80% | +72 points |
| Q2 2026 | 78% | +78 points |
| Q1 2026 | 69% | +180 points |
| Q4 2025 | 35% | +25 points |
| Q3 2025 | 7.6% | -9 points |
| Q2 2025 | 0.9% | N/A |
| Q1 2025 | -111% | -122 points |
| Q4 2024 | 10% | +6.6 points |
SNDK has the edge over MASK on profitability, with a higher operating margin.
MASK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2024 | $389.5K | +90% |
| Q2 2024 | $724.7K | +38% |
| Q4 2023 | $204.5K | -44% |
MASK's free cash flow has turned negative after years in the green: −$2M over the past year.
SNDK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.3B | +1340% |
| Q2 2026 | $7.1B | +14355% |
| Q1 2026 | $3B | +$3B |
| Q3 2025 | $438M | +$636M |
| Q2 2025 | $49M | +$217M |
| Q1 2025 | -$18M | +$23M |
| Q3 2024 | -$198M | -$157M |
SNDK has the edge over MASK in the latest year-over-year cash flow comparison.
MASK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +13% | +12.5K shares |
| 1 year | 0% | -- |
MASK has the edge over SNDK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2024 | $35,928 |
| Q3 2024 | — |
| Q2 2024 | $740,645 |
| Q1 2024 | — |
| Q4 2023 | $663,155 |
| Q2 2023 | $329,405 |
| Q4 2022 | — |
MASK spent $776,573 buying back its own shares over the past year.
SNDK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -1M shares |
| 1 year | +3.4% | +5M shares |
| 3 years | +6.9% | +10M shares |
SNDK has 154M diluted shares, up 3.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $5B |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
MASK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2024 | 0.0x | Very low |
| Q3 2024 | 0.0x | Very low |
MASK's net debt is less than a year of its operating earnings (EBITDA).
SNDK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.7x | Net Cash |
SNDK has more cash than debt.
MASK Weekly Momentum
As of the close on Nov 12, 2026: $1.85.
SNDK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.2 | Neutral |
| Stochastic | 10.6 | Oversold |
SNDK's weekly RSI is 40 (neutral) and its Stochastic is 11 (oversold).
MASK PE vs Technology Sector
MASK has no meaningful PE right now: it lost money over the past year.
SNDK PE vs Technology Sector
| Metric | SNDK | Sector median | Relative |
|---|---|---|---|
| PE | 7.5x | 28x | 73% below |
| PE % | 4 | 27 | 23 pts below |
SNDK is trading at 7.5x earnings, a 73% discount to the Technology sector's median of 28x, though its earnings don't support one.
MASK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.87 | 36% below |
SNDK has stronger trend alignment. MASK is above 0 of 1 weekly averages versus SNDK above 0 of 3.
SNDK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,317.5 | 29% below |
| 20 week MA | $1,465.4 | 36% below |
| 50 week MA | $1,119.6 | 16% below |
SNDK is in a downtrend: it's below all three of its weekly moving averages, and 16% below its 50-week average.
MASK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2026 YTD | $4.92 | $1.85 | -62% |
It's down 62% so far in 2026.
SNDK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $50.4 | $250.1 | +396% |
| 2026 YTD | $250.1 | $937.5 | +275% |
SNDK has the edge over MASK on returns for 2026, with the stronger performance.